» Articles » PMID: 25634119

Extracellular Volume Fraction in Dilated Cardiomyopathy Patients Without Obvious Late Gadolinium Enhancement: Comparison with Healthy Control Subjects

Overview
Publisher Springer
Specialty Radiology
Date 2015 Jan 31
PMID 25634119
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

To evaluate whether the extracellular volume fraction (ECV) measured using cardiac magnetic resonance (CMR) imaging can detect myocardial tissue changes in dilated cardiomyopathy (DCM) without late gadolinium enhancement (LGE). Forty-one DCM patients and 10 healthy volunteers underwent pre- and post-T1 mapping using a modified Look-Locker Inversion recovery sequence, LGE, and cine MRI on a 3-T CMR system. LGE-MR findings were used to divide DCM patients into two groups: Group A had no apparent LGE, and Group B had LGE apparent in at least one segment. The ECV of the left ventricle (LV) myocardium (16 segments) was calculated in the short-axis view as follows: ECV = [(ΔR1 of myocardium/ΔR1 of LV blood pool)] × (1 - hematocrit), where R1 = 1/T1, ΔR1 = post-contrast R1 - pre-contrast R1. The LV ejection fraction (LVEF) was obtained from cine MRI images. The mean myocardial ECV in LGE (-) segments in Group A + B was compared to that of controls. The mean myocardial ECV in Group A was compared to that of LGE (-) segments in Group B. The correlation between LV systolic function and the mean myocardial ECV of the whole myocardium was evaluated in all groups. Among the 41 DCM patients, 22 were in Group A, and 19 were in Group B. The mean ECV of DCM patents (n = 41, 568 segments, 30.7 % ± 5.9) was significantly higher (P < 0.001) than that of the control group (n = 10, 157 segments, 25.6 % ± 3.2). The ECV was inversely related to LVEF in Group A (r = -0.551, P = 0.008), Group B (r = -0.525, P = 0.021), and Group A + B (r = -0.550, P < 0.001). The ECV measured by MRI could be a useful parameter in evaluating diffuse myocardial changes in DCM patients.

Citing Articles

The effects of dipeptidyl peptidase-4 inhibitors on cardiac structure and function using cardiac magnetic resonance: a meta-analysis of clinical studies.

Wang H, Guo S, Gu S, Li C, Wang F, Zhao J Front Endocrinol (Lausanne). 2024; 15:1428160.

PMID: 39324124 PMC: 11422118. DOI: 10.3389/fendo.2024.1428160.


Utility of native T1 mapping and myocardial extracellular volume fraction in patients with nonischemic dilated cardiomyopathy: A systematic review and meta-analysis.

Tao M, Dhaliwal S, Ghosalkar D, Sheng S, Dianati-Maleki N, Tam E Int J Cardiol Heart Vasc. 2024; 51:101339.

PMID: 38371310 PMC: 10873728. DOI: 10.1016/j.ijcha.2024.101339.


Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis.

Gao Y, Wang H, Liu M, Gu H, Yuan X, Biekan J Eur Radiol. 2022; 33(3):1982-1991.

PMID: 36241919 DOI: 10.1007/s00330-022-09147-x.


Phantom-based correction for standardization of myocardial native T1 and extracellular volume fraction in healthy subjects at 3-Tesla cardiac magnetic resonance imaging.

Suh Y, Kim P, Park J, Park E, Jung J, Choi B Eur Radiol. 2022; 32(12):8122-8130.

PMID: 35771246 PMC: 9705515. DOI: 10.1007/s00330-022-08936-8.


Prognostic Cardiac Magnetic Resonance Markers of Left Ventricular Involvement in Arrhythmogenic Cardiomyopathy for Predicting Heart Failure Outcomes.

Chun K, Oh J, Hong Y, Yu H, Lee C, Kim T J Am Heart Assoc. 2022; 11(6):e023167.

PMID: 35261277 PMC: 9075293. DOI: 10.1161/JAHA.121.023167.


References
1.
Maron B, Towbin J, Thiene G, Antzelevitch C, Corrado D, Arnett D . Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and.... Circulation. 2006; 113(14):1807-16. DOI: 10.1161/CIRCULATIONAHA.106.174287. View

2.
Baldy C, Douek P, Croisille P, Magnin I, Revel D, Amiel M . Automated myocardial edge detection from breath-hold cine-MR images: evaluation of left ventricular volumes and mass. Magn Reson Imaging. 1994; 12(4):589-98. DOI: 10.1016/0730-725x(94)92453-8. View

3.
From A, Maleszewski J, Rihal C . Current status of endomyocardial biopsy. Mayo Clin Proc. 2011; 86(11):1095-102. PMC: 3203000. DOI: 10.4065/mcp.2011.0296. View

4.
Maisch B . Ventricular remodeling. Cardiology. 1996; 87 Suppl 1:2-10. DOI: 10.1159/000177160. View

5.
Klein C, Nekolla S, Balbach T, Schnackenburg B, Nagel E, Fleck E . The influence of myocardial blood flow and volume of distribution on late Gd-DTPA kinetics in ischemic heart failure. J Magn Reson Imaging. 2004; 20(4):588-93. DOI: 10.1002/jmri.20164. View